TKUMF yields 5.46% · JNJ yields 2.14%● Live data
📍 TKUMF pulled ahead of the other in Year 1
Combined, TKUMF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TKUMF + JNJ for your $10,000?
Takuma Co., Ltd. engages in the design, construction, and superintendence of various boilers, plant machineries, pollution prevention and environmental equipment plants, heating and cooling equipment, and feed water/drainage sanitation equipment and facilities in Japan and internationally. It operates through four segments: Domestic Environment and Energy Business, Overseas Environment and Energy Business, Package Boiler Business, and Equipment and System Business. The Domestic Environment and Energy Business segment operates general waste treatment, industrial waste treatment, waste recycling, wastewater treatment, sludge combustion, and biomass power plants. The Overseas Environment and Energy Business segment operates waste combusting and biomass power plants. The Package Boiler Business segment offers compact through-flow boilers and vacuum water heating systems. The Equipment and System Business segment provides construction equipment, and equipment for the semiconductor industry and cleaning systems. The company was formerly known as Takuma Boiler Manufacturing Co., Ltd. and changed its name to Takuma Co., Ltd. in 1972. Takuma Co., Ltd. was incorporated in 1938 and is headquartered in Amagasaki, Japan.
Full TKUMF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.